Tag: dispensaries
-
Plus Products (PLUS.C) 71% costs turnaround shows legitimacy in management, anchors growth
Esteemed California cannabis gummies maker Plus Products (PLUS.C) issued quarterly financials Thursday showing a substantial turnaround as their Nevada and national CBD growth plans take hold. After a 10c per share loss in Q1, the company presented a mere 1c per share loss in Q2, with $4.3 million in revenue, despite COVID-driven slowdowns in Nevada.…
-
iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal
For a large part of its early days, one of the main selling points of US multi state cannabis store operator iAnthus (IAN.C) was that it was seemingly run by adults. Unlike their colleagues at MedMen (MMEN.C), which revealed itself as a self-dealing executive wealth generator from day one, iAnthus painted a picture of experience,…
-
Choom Holdings (CHOO.C) snared in forgery scandal as location appeal reportedly contained fake support letters
National cannabis retail chain Choom Holdings (CHOO.C) was embarrassed Monday after details of its 27-page appeal to the Vancouver Board of Variance asking that body to overturn a rejected dispensary location were revealed to be forgeries by the Vancouver Sun newspaper. When Postmedia News contacted the businesses whose names and logos appear on letters supporting…
-
Shoppers Drug Mart (L.T) opens Toronto area same day delivery – and uses World Class Extractions (PUMP) to do it
Loblaws’ (L.T) big ass 1300-store pharmacy chain, Shoppers Drug Mart, announced this morning they’re now offering same day delivery of medical cannabis products in the Greater Toronto Area. Delivery will be free for orders over $100, which is most orders. Big news: The Medical Cannabis by Shoppers team is pleased to announce the launch of…
-
iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay…
-
MedMen (MMEN.C) CEO Adam Bierman resigns but his pockets continue to fill
From the day it landed on the stock market, MedMen (MMEN.C) was a company that drew derision and ire based almost entirely on the decision of its founders to lather themselves in hefty bonuses, hoard most of the voting shares, offer themselves enriching golden parachutes, and put themselves above the shareholders and the long term…
-
This is an actual MedMen (MMEN.C) news release
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new…
-
Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it
If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That’s not because we have a hate on for the dude-bros running the show, or because they’re not a…
-
MedMen (MMEN.C) yearly loss was $1m more than Supreme Cannabis’ (FIRE.T) entire market cap
“Fiscal 2019 was a transformative year for Medmen, with over two million completed retail transactions to date and revenues increasing 227% year-over-year,” said Adam Bierman, Medmen co-founder and chief executive officer in a news release that should see the company gutted on the markets Tuesday. Despite Bierman’s attempts at turd polishing, you don’t have to…